MedTrace Logo

Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences

NCT03335085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-11-07

No results posted yet for this study

Summary

This study evaluates whether intranasal administration of a single dose of oxytocin improves the ability to recognize emotional states. In a cross-over design, half of the participants first received oxytocin, the other half first received placebo.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

OTHER

Placebo

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • Ruhr University of Bochum

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-01
Primary Completion
2013-03-23
Completion
2013-11-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335085 on ClinicalTrials.gov